PT  - JOURNAL ARTICLE
AU  - Dehning, Jonas
AU  - Spitzner, F. Paul
AU  - Linden, Matthias C.
AU  - Mohr, Sebastian B.
AU  - Neto, Joao Pinheiro
AU  - Zierenberg, Johannes
AU  - Wibral, Michael
AU  - Wilczek, Michael
AU  - Priesemann, Viola
TI  - Model-based and model-free characterization of epidemic outbreaks
AID  - 10.1101/2020.09.16.20187484
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.16.20187484
4099  - http://medrxiv.org/content/early/2020/09/18/2020.09.16.20187484.short
4100  - http://medrxiv.org/content/early/2020/09/18/2020.09.16.20187484.full
AB  - Here, we provide detailed background information for our work on Bayesian inference of change-points in the spread of SARS-CoV-2 and the effectiveness of non-pharmaceutical interventions (Dehning et al., Science, 2020). We outline the general background of Bayesian inference and of SIR-like models. We explain the assumptions that underlie model-based estimates of the reproduction number and compare them to the assumptions that underlie model-free estimates, such as used in the Robert-Koch Institute situation reports. We highlight effects that originate from the two estimation approaches, and how they may cause differences in the inferred reproduction number. Furthermore, we explore the challenges that originate from data availability — such as publication delays and inconsistent testing — and explain their impact on the time-course of inferred case numbers. Along with alternative data sources, this allowed us to cross-check and verify our previous results.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAll authors received support from the Max-Planck-Society. JD and PS acknowledge funding by SMARTSTART, the joint training program in computational neuroscience by the VolkswagenStiftung and the Bernstein Network. JZ received financial support from the Joachim Herz Stiftung. MW is employed at the Campus Institute for Dynamics of Biological Networks funded by the VolkswagenStiftung.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:-All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe provide the code for generating graphics and all the different analyses included this manuscript and its supplementary materials at https://github.com/Priesemann-Group/covid19_research/tree/master/Technical%20notes%20on%20Dehning%20et%20al.%2C%20Science%2C%202020